retatrutide mechanism glp-1 gip glucagon triple agonist Retatrutide

Heterogeneity in response to GLP 1 receptor agonists in type 2 diabetes in real world clinical practice: insights from the DPV register an IMI SOPHIA study Diabetologia Springer Nature Link Gastrointestinal Motility Effects of GLP 1 Receptor Agonists Current Gastroenterology Reports Springer Nature Link To begin our 5 week series on GLP 1 medications, we're starting with an important topic: Nutrition and GLP 1s. GLP 1 medications work by: Reducing hunger and appetite Decreasing comfort eating and food Treatment with retatrutide, an agonist to GLP 1, GIP, and glucagon receptors in one molecule, was associated with unprecedented drops in weight from people with or without type 2 diabetes in a pair The Synergy of Phentermine & GLP 1 RAs for Healthy Weight Management & in Addressing Obesity by Dr Mehmet Yildiz EUPHORIA Medium